Global Herpes Zoster Therapeutic Development Review, H1 2015

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.

Complete report on H1 2015 pipeline review of Herpes Zoster (Shingles) addiction with 23 market data tables and 13 figures, spread across 61 pages is available at http://www.rnrmarketresearch.com/herpes-zoster-shingles-pipeline-review-h1-2015-market-report.html . (This is a premium report price at US$2000 for a single user PDF license)

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope:

• The report provides a snapshot of the global therapeutic landscape of Herpes Zoster (Shingles)

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Herpes Zoster (Shingles) and enlists all their major and minor projects

• The report summarizes all the dormant and discontinued pipeline projects

• A review of the Herpes Zoster (Shingles) products under development by companies...